Patents Assigned to Robozyme Pharmaceuticals, Inc. - Justia Patents Search

Patents Assigned to Robozyme Pharmaceuticals, Inc.

Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors

Patent number: 6057156

Abstract: Enzymatic nucleic acid molecules which cleave EGFR RNA.

Type: Grant

Filed: December 4, 1997

Date of Patent: May 2, 2000

Assignee: Robozyme Pharmaceuticals, Inc.

Inventors: Saghir Akhtar, Patricia Fell, James A. McSwiggen